Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01301378 · ClinicalTrials.gov registry record · NA
Patch Graft Material Safety and Effectiveness in Covering Glaucoma Drainage Device Tube
A NA study, sponsored by Wills Eye.
- Terminated
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT01301378 is a NA study that was terminated before completion, run by Wills Eye. The registered enrollment target is 40 participants.
The verdict
NCT01301378, a NA study, was terminated before completion, sponsored by Wills Eye.
- TERMINATED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The investigators hypothesize that KeraSys is a safe as Tutoplast to cover the tube of the Molteno 3 glaucoma drainage device during surgery
Interventions
- PROCEDURE Molteno 3 glaucoma drainage shunt
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2010-08 |
| Est. Completion | 2011-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01301378
The ClinicalTrials.gov registry entry for NCT01301378 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wills Eye, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Molteno 3 glaucoma drainage shunt is the first listed.
NCT01301378 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01301378 about?
NCT01301378 is a clinical study titled "Patch Graft Material Safety and Effectiveness in Covering Glaucoma Drainage Device Tube". The investigators hypothesize that KeraSys is a safe as Tutoplast to cover the tube of the Molteno 3 glaucoma drainage device during surgery
What is the current status of trial NCT01301378?
This trial is currently terminated. It is a NA study. The enrollment target is 40 participants. The study started on 2010-08. Estimated completion is 2011-01.
What interventions are being tested in trial NCT01301378?
The interventions under investigation include: Molteno 3 glaucoma drainage shunt (PROCEDURE).
Who is sponsoring clinical trial NCT01301378?
This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.